Dynamk Capital

Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.

Dynamk Capital favicon
Founded 2017 ยท venture_capital
Investment Stages
seed
series-a
series-b
Portfolio Companies

Virica Biotech, Lucid Scientific, Alpenglow Biosciences, CellFE Biotech, Curibio, RoosterBio, Vectron Biosolutions, Vernal Biosciences, CellFE Biotech, Envisagenics, RESIPHER, Xcell Bioscience

Contacts
Unlock contacts with credits
Share this page